Moderna ’s (NASDAQ:MRNA) Latest Cancer Treatment Gives Shares New Life
For a while, things weren’t looking all that great for biotech stock Moderna (NASDAQ:MRNA). Its primary stock in trade, the COVID-19 vaccine, has b...
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Cancer Vaccines | Covid Vaccine | COVID-19 | Health | Vaccines